Age-Related Changes in Pain Peptides CGRP and Substance P in Spinal Nerve Cells
Aging increases CGRP and substance P expression in lumbar dorsal root ganglia in mice, contributing to the pain sensitization and inflammation associated with spinal degeneration.
Quick Facts
What This Study Found
Chronological aging increases CGRP and substance P in lumbar DRG neurons, with concurrent signs of sensitization and inflammation that parallel disc degeneration.
Key Numbers
Calca/ATF3/BDNF ↑ linearly from 12mo; TAC1 protein ↑ 24mo; Nfkb1/Rela ↑; TNF/IL-6/IL-1β/COX-2 unchanged
How They Did This
Age-series mouse study with molecular analysis of neuropeptide expression, inflammatory markers, and sensitization indicators in lumbar DRG neurons.
Why This Research Matters
Back pain is extremely common in aging populations but its molecular mechanisms are poorly understood. This study connects neuropeptide changes in sensory neurons to age-related disc degeneration.
The Bigger Picture
Understanding the neuropeptide basis of age-related pain could lead to targeted therapies like CGRP or substance P blockers for chronic back pain in the elderly.
What This Study Doesn't Tell Us
Mouse study — aging patterns may differ in humans. Correlative data cannot establish causation between neuropeptide changes and pain.
Questions This Raises
- ?Would CGRP or NK1R antagonists reduce age-related back pain?
- ?Are similar neuropeptide changes found in human aging DRG?
- ?Do the neuropeptide changes cause pain or just accompany degeneration?
Trust & Context
- Key Stat:
- Age-dependent increase CGRP and substance P expression rises with age in lumbar DRG neurons, paralleling disc degeneration
- Evidence Grade:
- Animal study with correlative molecular data. Provides mechanistic insight but needs human validation.
- Study Age:
- Published in 2020. Neuropeptide-targeted pain therapies continue to be developed.
- Original Title:
- Age-related molecular changes in the lumbar dorsal root ganglia of mice: Signs of sensitization, and inflammatory response.
- Published In:
- JOR spine, 3(4), e1124 (2020)
- Authors:
- Vincent, Kathleen, Dona, Chethana Prabodhanie Gallage, Albert, Todd J(2), Dahia, Chitra Lekha
- Database ID:
- RPEP-05185
Evidence Hierarchy
Frequently Asked Questions
Why does back pain increase with age?
This study shows that as mice age, their spinal nerve cells produce more CGRP and substance P — peptides that transmit and amplify pain signals. This molecular change accompanies disc degeneration and may explain why chronic back pain becomes more common with aging.
Could migraine drugs help with back pain?
Potentially. CGRP-blocking drugs approved for migraines target the same peptide found to increase in aging spinal nerves. If age-related CGRP elevation drives back pain, these drugs might help, though this hypothesis needs clinical testing.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05185APA
Vincent, Kathleen; Dona, Chethana Prabodhanie Gallage; Albert, Todd J; Dahia, Chitra Lekha. (2020). Age-related molecular changes in the lumbar dorsal root ganglia of mice: Signs of sensitization, and inflammatory response.. JOR spine, 3(4), e1124. https://doi.org/10.1002/jsp2.1124
MLA
Vincent, Kathleen, et al. "Age-related molecular changes in the lumbar dorsal root ganglia of mice: Signs of sensitization, and inflammatory response.." JOR spine, 2020. https://doi.org/10.1002/jsp2.1124
RethinkPeptides
RethinkPeptides Research Database. "Age-related molecular changes in the lumbar dorsal root gang..." RPEP-05185. Retrieved from https://rethinkpeptides.com/research/vincent-2020-agerelated-molecular-changes-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.